References
Teijeira, A. et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity 52, 856–71 e8 (2020).
Koch, J. & Tesar, M. Recombinant antibodies to arm cytotoxic lymphocytes in cancer immunotherapy. Transfus. Med Hemother. 44, 337–350 (2017).
Dunn, G. P., Old, L. J. & Schreiber, R. D. The three Es of cancer immunoediting. Annu Rev. Immunol. 22, 329–360 (2004).
Masuda, S. et al. NETosis markers: quest for specific, objective, and quantitative markers. Clin. Chim. Acta 459, 89–93 (2016).
Jaillon, S. et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer. 2020. In press. https://doi.org/10.1038/s41568-020-0281-y.
Garley, M., Jablonska, E. & Dabrowska, D. NETs in cancer. Tumour Biol. 37, 14355–14361 (2016).
Cruz, F. M., Colbert, J. D., Merino, E., Kriegsman, B. A. & Rock, K. L. The biology and underlying mechanisms of cross-presentation of exogenous antigens on MHC-I molecules. Annu. Rev. Immunol. 35, 149–176 (2017).
Doni, A. et al. The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer. Front Immunol. 10, 712 (2019).
Daigo, K., Takamatsu, Y. & Hamakubo, T. The protective effect against extracellular histones afforded by long-pentraxin PTX3 as a regulator of NETs. Front Immunol. 7, 344 (2016).
Baruah, P. et al. The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens. Blood 107, 151–158 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
De Santis, M., Mantovani, A. & Selmi, C. The other side of the innate immune system: humoral arms favoring cancer. Cell Mol Immunol 17, 1024–1025 (2020). https://doi.org/10.1038/s41423-020-0512-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-020-0512-x
- Springer Nature Limited
This article is cited by
-
Inhibition of NETosis for treatment purposes: friend or foe?
Molecular and Cellular Biochemistry (2022)